Verastem | VSTM - Cost Of Sales

Stock Price
5.91
Daily Change
-0.61 -9.36%
Monthly
9.65%
Yearly
-16.05%
Q2 Forecast
6.44

Verastem reported $2.89M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
AstraZeneca USD 3.27B 471M Dec/2025
Curis USD 314K 9.96M Dec/2025
Cytokinetics USD 99.23M 13.32M Sep/2025
Gilead Sciences USD 1.62B 50M Dec/2025
Incyte USD 121.18M 22.18M Dec/2025
Laboratory Of America USD 2.6B 56.8M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Pfizer USD 6.29B 2.12B Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
TG Therapeutics USD 38.14M 10.05M Dec/2025
Verastem USD 2.89M 2.88M Dec/2025